ANAVEX LIFE SCIENCES CORP. Quarterly Current Income Tax Expense (Benefit) in USD from Q4 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Anavex Life Sciences Corp. quarterly/annual Current Income Tax Expense (Benefit) history and growth rate from Q4 2015 to Q2 2024.
  • Anavex Life Sciences Corp. Current Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$67K, a 263% decline year-over-year.
  • Anavex Life Sciences Corp. Current Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $59K, a 79% decline year-over-year.
  • Anavex Life Sciences Corp. annual Current Income Tax Expense (Benefit) for 2023 was $7K, a 98% decline from 2022.
  • Anavex Life Sciences Corp. annual Current Income Tax Expense (Benefit) for 2022 was $358K, a 33.6% increase from 2021.
  • Anavex Life Sciences Corp. annual Current Income Tax Expense (Benefit) for 2021 was $268K, a 1082% increase from 2020.
Current Income Tax Expense (Benefit), Trailing 12 Months (USD)
Current Income Tax Expense (Benefit), Quarterly (USD)
Current Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $59K -$67K -$108K -263% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $167K $105K +$55K +110% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $112K $85K +$105K Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $7K -$64K -$274K -131% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-27
Q2 2023 $281K $41K -$47.4K -53.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $328K $50K +$20.2K +67.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $308K -$20K -$50K -167% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q3 2022 $358K $210K +$67.1K +47% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-27
Q2 2022 $291K $88.4K +$49.4K +127% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $242K $29.8K +$2.81K +10.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $239K $30K -$29.3K -49.4% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 $268K $143K +$134K +1553% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-27
Q2 2021 $134K $39K +$34.2K +710% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $99.7K $27K +$27K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $72.7K $59.3K +$50.1K +543% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $22.7K $8.63K +$2.52K +41.2% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-28
Q2 2020 $20.1K $4.82K -$14.5K -75% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $34.6K $0 -$48K -100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $82.7K $9.21K +$497 +5.7% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $82.2K $6.12K Jul 1, 2019 Sep 30, 2019 10-K 2020-12-28
Q2 2019 $19.3K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $48K +$20.2K +72.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $8.72K -$688 -7.32% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q1 2018 $56.3K $27.9K +$18.3K +190% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $38K $9.41K -$21.6K -69.7% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $59.6K $9.13K Jul 1, 2017 Sep 30, 2017 10-K/A 2019-01-25
Q2 2017 $9.88K +$3.88K +64.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $9.6K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $31K +$13.4K +76% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q2 2016 $6K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q4 2015 $17.6K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.